Yezan Munther Haddadin, Director: Outlook Therapeutics OTLK Buy · Filed 06/03

Trade details

Type: Insider buy
Amount: $24,070
Shares · price: 29,000 sh · $0.83 a share
Held after: 66,167 sh
Stock: Outlook Therapeutics OTLK
Person: Yezan Munther HaddadinDirector
Trade date: 26/06/02
Filed: 26/06/03
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 6 insiders
Holding change: +78.0%

Outlook Therapeutics trades, last 26 weeks

What else happened in Outlook Therapeutics around then

Filed or reported within 30 days of the trade day · 05/03~07/02

Yezan Munther Haddadin's recent trades

Yezan Munther HaddadinDirector
BuyOutlook Therapeutics
Buy
Outlook Therapeutics
OTLK
$15K
34,000 sh
$15K
Filed 05/27
Traded 05/26
Yezan Munther HaddadinDirector
BuyOutlook Therapeutics
Buy
Outlook Therapeutics
OTLK
$22.2K
1,881.71 sh
$22.2K
Filed 24/03/29
Traded 24/03/28